Document Intelligence for
Pharmaceutical Manufacturing
cGMP batch record processing, FMEA extraction, equipment qualification (IQ/OQ/PQ), and cleaning validation documentation. Full audit trail and data integrity.
cGMP batch record digitization: structured extraction from manual batch records and MBRs into electronic batch record (EBR) systems
Equipment qualification (IQ / OQ / PQ) documentation: structured protocol and execution records linked to P&IDs, datasheets, and calibration certificates
Cleaning validation documentation: CIP / SIP study records, residue limit calculations, swab and rinse sample traceability
HVAC and cleanroom P&ID extraction: ISO 14644 classified zones, air-change rates, differential pressure cascades, HEPA filter registers
FMEA extraction per ICH Q9 / ICH Q10: risk registers with severity, occurrence, detection ratings and CAPA linkage
Utility validation documentation: WFI (Water for Injection), purified water, pure steam, compressed air, nitrogen, USP <643> / <645> compliance
21 CFR Part 11 / EU Annex 11 compliant electronic records: every extracted field carries e-signature, timestamp, audit trail provenance
Change control documentation: MoC records with GMP impact assessment and regulatory submission readiness
Process validation and CPV (continued process verification) documentation: PPQ batches, process parameter tracking
Deviation / CAPA / OOS (out-of-specification) document structuring for QMS integration (Veeva, MasterControl, TrackWise, ComplianceWire)
Vendor qualification and supplier document management: material supplier GMP audits, quality agreements, change notifications
Regulatory submission document compilation: CTD modules, ANDA / NDA / MAA dossiers, BLA / INDA / CBE-30 variations
Why do pharmaceutical plants need engineering document intelligence?
Pharmaceutical manufacturing operates under the strictest documentation regime of any process industry: cGMP requires documented evidence of every process step, every equipment qualification, every cleaning validation, every deviation, every change control, every operator action. USFDA 21 CFR Part 11, EU GMP Annex 11, WHO-GMP, and national equivalents (CDSCO in India, PMDA in Japan) all require this documentation to be current, data-integrity-compliant (ALCOA+), and audit-ready at all times. A single documentation gap at USFDA inspection can trigger a 483 observation, warning letter, consent decree, or import alert, with commercial consequences measured in hundreds of crores for Indian generics exporters. Document intelligence automates the documentation workflow that historically consumed 15-25% of pharma engineering and QA workforce time, with materially higher compliance posture than manual management can deliver.
How does document intelligence support pharma equipment qualification?
Equipment qualification (IQ / OQ / PQ) in pharma is documentation-intensive: every instrument carries a qualification protocol, every control loop needs operational qualification evidence, every cleaning procedure needs performance qualification. A typical 10-line pharmaceutical facility carries 2,000-5,000 qualification records across equipment, instruments, utilities, cleanrooms, and computerised systems. Pathnovo extracts and cross-references data from P&IDs, instrument datasheets, qualification protocols, execution reports, and calibration records to build complete equipment qualification packages, eliminating weeks of manual compilation and dramatically improving audit readiness. For biologics and ATMP (Advanced Therapy Medicinal Products) facilities with even tighter qualification requirements, the benefit compounds further.
How does Pathnovo handle pharmaceutical document intelligence under cGMP?
Pathnovo processes the full cGMP document set: batch records, equipment qualification documents (IQ/OQ/PQ), FMEA studies per ICH Q9, cleaning validation records (CIP / SIP / residue studies), HVAC / cleanroom P&IDs, utility validation records, and process validation (PPQ) documentation. All extraction follows pharmaceutical-grade quality standards with full audit trails, data integrity controls per ALCOA+ principles, and evidence chain back to source document for every extracted field. Typical engagement scope: 500-5,000+ documents per facility with 99.5% contractual accuracy SLA.
Is Pathnovo compliant with 21 CFR Part 11 and EU Annex 11?
Yes. Pathnovo's extraction workflow supports 21 CFR Part 11 (USFDA electronic records / electronic signatures) and EU Annex 11 (EU GMP computerised systems) compliance through: (1) full audit trail of every extraction transaction with user ID, timestamp, and action captured; (2) e-signature-ready data records with immutable provenance; (3) data integrity per ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available); (4) every extracted field linked to source document page and bounding-box coordinate; (5) validated extraction pipeline with IQ/OQ/PQ documentation available for client CSV efforts.
Does Pathnovo support CSV (Computer System Validation) for GxP-regulated environments?
Yes. Pathnovo provides validation documentation to support client CSV efforts: URS (User Requirement Specification) templates, FS (Functional Specification) documentation, IQ / OQ / PQ protocols for the extraction system as used in the client environment, traceability matrices linking user requirements to test scripts, accuracy verification reports, and ongoing validation protocol maintenance. Pathnovo operates under validated SDLC practices suitable for GxP-regulated manufacturing.
Which pharma operators does Pathnovo serve?
Indian generics leaders: Dr Reddy's Laboratories, Aurobindo Pharma, Sun Pharmaceutical, Cipla, Lupin, Divi's Laboratories, Granules India, Natco Pharma, Hetero Drugs, Laurus Labs, MSN Laboratories, Alkem, Glenmark, Torrent Pharma, Zydus Lifesciences, Biocon. Global innovator companies and CDMOs: Teva, Novartis, Pfizer, GSK, Merck, Johnson & Johnson Indian operations, plus major CDMOs (Syngene, Piramal Pharma Solutions, Siegfried, Fareva). Pharmaceutical engineering consultancies and EPC firms (Jacobs, IPS-Integrated Project Services, NNE) also served. See /regions/india/hyderabad for pharma cluster regional context.
How does Pathnovo integrate with pharma QMS platforms?
Pre-configured export formats for major pharma QMS systems: Veeva QualityOne / Vault QMS, MasterControl, TrackWise (Sparta Systems), ComplianceWire, ETQ Reliance, Pilgrim SmartSolve, AmpleLogic. Extracted GMP data (deviations, CAPAs, change controls, batch records) flows structured into the target QMS as part of the ongoing operational compliance layer. Engineering data (P&IDs, datasheets, equipment qualification) additionally feeds SAP PM / IBM Maximo for asset-lifecycle maintenance. See /solutions/engineering-handover.
Can Pathnovo support USFDA / EMA / MHRA / WHO-GMP audit readiness?
Yes. Audit-readiness is a headline benefit. USFDA 483 observations and EMA GMP inspection findings most commonly arise from: (1) incomplete documentation trails, (2) data integrity gaps, (3) missing CAPA closure evidence, (4) outdated P&ID versus installed equipment. Pathnovo's structured, audit-trailed extraction addresses all four. For regulatory re-inspections, USFDA warning letter remediation, and EU GMP periodic inspection preparation, Pathnovo compresses 4-8 weeks of manual document reconciliation into a continuous, always-current register.
See what your documents actually contain.
Send us 10 documents from your current project. We extract, reconcile, and show you exactly what we find in 48 hours, before any contract.
If the accuracy isn't what we promised, you owe us nothing.